New pill aims to quiet chronic hives without the itch
Symptom relief
Not yet recruiting
This early-stage trial tests an experimental tablet called Alpha-0261 in people with chronic spontaneous urticaria (long-lasting hives) and in healthy volunteers. The study checks the drug's safety, how the body processes it, and whether it reduces hive activity and itching. Part…
Phase: PHASE1 • Sponsor: AlphaMol Science Ltd. (Shanghai) • Aim: Symptom relief
Last updated Jul 08, 2026 00:00 UTC